Key facts
- This page summarizes Jerman Michael A.'s Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Oct 2026, 16:30.
Jerman Michael A. - 06 Oct 2026 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)
- Reporting relationship
- Director
- Issuer ticker
- TCRT
- Reported as of
- 06 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Oct 2026, 16:30:09 UTC
- Prior SEC filing
- 27 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- Jerman Michael A
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jerman Michael A. filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 08 Oct 2026.
Change
- Previous filing in this sequence was filed on 27 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001979732
Primary reporting owner
Jerman Michael Allen
- Relationship
- Director
- Address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE
- Signature
- Jerman Michael A
- Signature date
- 08 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TCRT
transaction
Common Stock
Award
- Transaction value
- Shares
- +20,990
- Change %
- +88%
- Price
- $0.7444*
- Shares after
- 44,749
- Date
- 06 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares of common stock issued in lieu of board fees.